CAPTRUST FINANCIAL ADVISORS - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 67 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$0
-100.0%
1000.0%0.00%
Q2 2021$1,0001000.0%0.00%
Q1 2021$01000.0%0.00%
Q4 2020$01000.0%0.00%
Q3 2020$01000.0%0.00%
Q2 2020$0
-100.0%
1000.0%0.00%
Q3 2019$1,0000.0%1000.0%0.00%
Q2 2019$1,0000.0%1000.0%0.00%
Q1 2019$1,0001000.0%0.00%
Q4 2018$0
-100.0%
1000.0%0.00%
Q3 2018$1,0000.0%1000.0%0.00%
Q2 2018$1,0000.0%1000.0%0.00%
Q1 2018$1,0001000.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Cruiser Capital Advisors, LLC 36,888$301,0000.15%
Kazazian Asset Management, LLC 18,792$153,0000.14%
Fiduciary Trust Co International of Pennsylvania 202,100$1,649,0000.07%
Engineers Gate Manager LP 66,270$541,0000.04%
THOMPSON DAVIS & CO., INC. 1,534$13,0000.03%
ZEKE CAPITAL ADVISORS, LLC 23,700$193,0000.02%
A.R.T. Advisors, LLC 43,360$353,0000.02%
Cutler Group LLC / CA 20,822$186,0000.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 63,614$519,000,0000.01%
FNY Investment Advisers, LLC 6,000$48,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders